Aevum Zenth Conglomerate Inc.
Commission File Number: 001-38924
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2025
| State of Incorporation: | Delaware |
| I.R.S. Employer ID: | 84-2910375 |
| Principal Executive Offices: | Zenth Tower, Neo Geneva District, Global HQ |
Executive Summary
2025 marked a historic year for Aevum Zenth, with consolidated revenues reaching $94.3B, a 12.4% year-over-year increase, driven by accelerated adoption of AI infrastructure, expansion of renewable energy portfolios, and strategic M&A in healthcare and aerospace sectors.
Our multidivisional strategy continues to deliver resilient growth across cyclical and defensive markets. Key highlights include the successful commercialization of next-generation fusion pilot plants, record-breaking satellite deployment velocity, and the launch of our unified enterprise AI platform across 22 subsidiaries.
Operating margins expanded to 18.7%, reflecting disciplined capital allocation, supply chain optimization, and cross-divisional technology transfer efficiencies. We remain committed to sustainable growth, long-term value creation, and operational excellence across all 400 entities.
Consolidated Financial Highlights
All figures in millions USD, except per share data.
| Metric | FY 2025 | FY 2024 | YoY Change |
|---|---|---|---|
| Total Revenue | $94,312 | $83,875 | +12.4% |
| Gross Profit | $41,880 | $36,105 | +16.0% |
| Operating Income | $17,636 | $15,088 | +16.9% |
| Net Income | $11,204 | $9,410 | +19.1% |
| Diluted EPS | $4.82 | $4.15 | +16.1% |
| Free Cash Flow | $14,150 | $11,890 | +19.0% |
| Total Assets | $218,400 | $194,200 | +12.5% |
Revenue growth was primarily driven by the Technology Division (+18.2%), Energy Division (+14.5%), and Aerospace & Defense (+11.8%). The Finance and Healthcare divisions maintained steady double-digit growth, while Real Estate and Logistics showed resilience amid macroeconomic headwinds.
Management's Discussion & Analysis (MD&A)
Operating Performance
Our integrated operating model continues to yield significant synergies. Cross-divisional R&D spending reached $12.1B in 2025, representing 12.8% of total revenue. This investment underpins our competitive moat in quantum computing, advanced materials, and autonomous systems.
Liquidity & Capital Resources
As of December 31, 2025, we maintained $28.4B in cash and short-term investments. We repurchased $4.2B of common stock and paid $2.8B in dividends. Our investment-grade credit rating (Aa3/AA-) reflects strong balance sheet fundamentals and consistent cash generation.
Outlook
For FY 2026, we expect revenue growth of 10-12%, driven by contracted government defense programs, commercial space infrastructure deployments, and enterprise AI adoption. We will continue to prioritize shareholder returns through disciplined capital deployment and strategic acquisitions.
Risk Factors
Investing in our common stock involves substantial risks. You should carefully consider the following factors:
- Regulatory & Compliance Exposure: Operating across 62 jurisdictions subjects us to complex, evolving regulatory frameworks, particularly in data privacy, aerospace, pharmaceuticals, and financial services.
- Geopolitical & Supply Chain Volatility: Global trade tensions, export controls, and regional conflicts may disrupt critical component sourcing and international project execution.
- Technology Obsolescence & Cyber Threats: Rapid innovation cycles require continuous R&D investment. Cyber incidents could compromise proprietary systems, customer data, or operational infrastructure.
- Integration Risk from M&A: Acquiring and integrating diverse businesses across industries presents cultural, operational, and financial integration challenges.
- Environmental & Climate Transition: Stricter emissions standards and carbon pricing mechanisms may impact legacy operations, though our green energy transition strategy mitigates long-term exposure.
Certifications & Compliance
Management certifies that the annual report fairly presents, in all material respects, the financial condition and results of operations of Aevum Zenth Conglomerate Inc.
This filing complies with SEC Regulation S-K, Regulation S-X, and applicable international financial reporting standards (IFRS/GAAP). Independent audit conducted by Deloitte Touche Tohmatsu Limited.
All internal controls over financial reporting as of December 31, 2025, have been evaluated and deemed effective. No material weaknesses were identified during the fiscal year.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
(Principal Executive Officer)
(Principal Financial Officer)
Dated: March 14, 2026